Fluoxetine is one of the most studied and detected selective serotonin reuptake inhibitors in
the aquatic environment, found at concentrations ranging from ng/L to μg/L. Its presence in …

Antidepressant (AD) drugs are widely prescribed for the treatment of psychiatric disorders,
including depression and anxiety disorders. The continuous use of ADs causes significant …

Many studies have quantified pharmaceuticals in the environment, few however, have
incorporated detailed temporal and spatial variability due to associated costs in terms of time …

Antidepressants are one of the most commonly prescribed pharmaceutical classes for the
treatment of psychiatric conditions. They act via modulation of brain monoaminergic …

Pharmaceutical active compounds (PhACs) are increasingly being reported in wastewater
effluents and surface waters around the world. The presence of these products, designed to …

Pharmaceutical pollutants constitute a major threat to wildlife because of their capacity to
induce biological effects at low doses. One such pollutant is the antidepressant fluoxetine …

Contamination of aquatic habitats with pharmaceuticals is a major environmental concern.
Recent studies have detected pharmaceutical pollutants in a wide array of ecosystems and …

Chemical pollution from pharmaceuticals is increasingly recognized as a major hazard to
the aquatic biota. Among the wide variety of pharmaceuticals, fluoxetine (FLX) is one of the …

We studied the adverse effects of four benzodiazepines frequently measured in European
surface waters. We evaluated bioaccumulation potential of oxazepam, bromazepam …

Pharmaceutical contamination is an increasing problem globally. In this regard, the selective
serotonin reuptake inhibitors (SSRIs)—a group of antidepressants—are particularly …